- Accueil >
- Publications >
- Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Auteurs
Stefano Kim, Eric François, Thierry André, Emmanuelle Samalin, Marine Jary, Farid El Hajbi, Nabil Baba-Hamed, Simon Pernot, Marie-Christine Kaminsky, Olivier Bouché, Jérôme Desrame, Mustapha Zoubir, François Ghiringhelli, Aurélie Parzy, Christelle De La Fouchardiere, Denis Smith, Mélanie Deberne, Laurie Spehner, Nicolas Badet, Olivier Adotevi, Amélie Anota, Aurélia Meurisse, Dewi Vernerey, Julien Taieb, Véronique Vendrely, Bruno Buecher, Christophe Borg